| 000 | 01210 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250514072718.0 | ||
| 264 | 0 | _c20030711 | |
| 008 | 200307s 0 0 eng d | ||
| 022 | _a1543-1622 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 245 | 0 | 0 |
_aBrachytherapy for accelerated partial breast irradiation after breast-conserving surgery for early stage breast cancer. _h[electronic resource] |
| 260 |
_bTEC bulletin _cNov 2002 |
||
| 300 |
_a6-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aBlue Cross Blue Shield Insurance Plans |
| 650 | 0 | 4 | _aBrachytherapy |
| 650 | 0 | 4 |
_aBreast Neoplasms _xradiotherapy |
| 650 | 0 | 4 | _aDrug Approval |
| 650 | 0 | 4 | _aEvidence-Based Medicine |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInsurance Coverage |
| 650 | 0 | 4 | _aMastectomy, Segmental |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdiagnostic imaging |
| 650 | 0 | 4 | _aOutcome Assessment, Health Care |
| 650 | 0 | 4 | _aRadiography |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aTechnology Assessment, Biomedical |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 773 | 0 |
_tTEC bulletin _gvol. 19 _gno. 3 _gp. 6-9 |
|
| 999 |
_c12621364 _d12621364 |
||